Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 7/2015

01-07-2015 | Literatur kommentiert

Sollte man nach brusterhaltender Therapie bei Frauen über 65 Jahren mit einem frühen Mammakarzinom auf die adjuvante Radiotherapie verzichten?

Author: Dr. med. David Krug

Published in: Strahlentherapie und Onkologie | Issue 7/2015

Login to get access

Auszug

Mehrere randomisierte Studien haben gezeigt, dass der Verzicht auf die adjuvante Radiotherapie nach brusterhaltender Operation auch bei älteren Frauen mit Niedrigrisiko-Tumoren mit einem erhöhten Lokalrezidivrisiko einhergeht. Dies wird hier noch einmal an einem großen Patientengut untersucht. …
Literature
1.
Blamey RW, Bates T, Chetty U et al (2013) Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer 49:2294–2302PubMedCrossRef
2.
Canavan J, Truong PT, Smith SL et al (2014) Local recurrence in women with stage I breast cancer: declining rates over time in a large, population-based cohort. Int J Radiat Oncol Biol Phys 88:80–86PubMedCrossRef
3.
Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31:2382–2387PubMedCentralPubMedCrossRef
4.
Kunkler IH, Williams LJ, Jack WJ et al (2015) Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 16:266–273PubMedCrossRef
5.
Sautter-Bihl ML, Sedlmayer F, Budach W et al (2012) When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol 188:1069–1073PubMedCrossRef
6.
Sheppard VB, Faul LA, Luta G et al (2014) Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901. J Clin Oncol 32:2318–2327PubMedCrossRef
7.
Smith BD, Gross CP, Smith GL et al (2006) Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98:681–690PubMedCrossRef
8.
Van De Water W, Bastiaannet E, Scholten AN et al (2014) Breast-conserving surgery with or without radiotherapy in older breast patients with early stage breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 21:786–794PubMedCrossRef
9.
Williams LJ, Kunkler IH, King CC et al (2011) A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial. Health Technol Assess 15:i–xi, 1–57PubMedCrossRef
10.
Winzer KJ, Sauerbrei W, Braun M et al (2010) Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 × 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 46:95–101PubMedCrossRef
Metadata
Title
Sollte man nach brusterhaltender Therapie bei Frauen über 65 Jahren mit einem frühen Mammakarzinom auf die adjuvante Radiotherapie verzichten?
Author
Dr. med. David Krug
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 7/2015
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-015-0846-y

Other articles of this Issue 7/2015

Strahlentherapie und Onkologie 7/2015 Go to the issue

Original Article

Long-term side effects of radiotherapy for pediatric localized neuroblastoma

Original Article

Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma

Original Article

Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer

Original Article

Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer

Original Article

DEGRO guidelines for the radiotherapy of non-malignant disorders

Literatur kommentiert

Effekt der additiven Boost-Bestrahlung bei der Radiotherapie nach brusterhaltender Operation des frühen Mammakarzinoms